This article reviews the history and various techniques of using microsurgical free scalp flaps for hair restoration in male pattern baldness, reporting no new research findings.
September 2009 in “European Urology Supplements” Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.
This chapter discusses phase transitions in various pharmaceutical examples and does not present any new research findings.
January 2004 in “Chinese Journal of Medical Aesthetics and Cosmetology” This study reported that autogenous hair transplantation resulted in good hair growth for seborrheic hair loss, but hair density was influenced by donor hair density and hair loss area.
September 2002 in “Dermatologic Surgery” This article offers guidance for hair transplant surgeons on addressing old or poorly executed transplants, focusing on surgical precision and effective use of limited donor hair to enhance cosmetic outcomes.
August 2001 in “Dermatologic Surgery” This study found that using the KNU implanter for follicular unit transplantation resulted in a high survival rate of 92% at 6 months, regardless of whether one-hair or two-hair units were used.
This abstract contains no research findings; it outlines website features and access options for the JAMA network's publications.
August 2026 in “Frontiers in Surgery” This review article from the examined literature highlights the shift in eyebrow reconstruction techniques from traditional methods to minimally invasive and regenerative approaches, evaluating their principles, outcomes, and challenges to inform future clinical practices.
July 2026 in “Current Problems in Surgery” This narrative review reports that tissue-engineered scaffolds for wound healing generally match standard care outcomes, with some trials indicating faster healing and improved scar quality, despite challenges like limited cellular infiltration and inadequate vascularization.
July 2026 in “Advanced Healthcare Materials” This review discusses the potential of silk fibroin-based injectable hydrogels as next-generation biomaterials for regenerative medicine, exploring their therapeutic advantages, challenges, and future clinical applications.
July 2026 in “Industrial Crops and Products” This review highlights the potential of Illicium verum in enhancing bioactive compound efficacy and stability through nanotechnology, despite challenges in physicochemical limitations and regulatory hurdles.
July 2026 in “Frontiers in Bioengineering and Biotechnology” This review highlights that Microneedle Hydrogels may offer promising advantages for diabetic foot ulcer treatment due to their minimally invasive application and effective drug delivery capabilities.
July 2026 in “Advanced Biology” This study introduces novel wound dressings with hydrophobic properties, highlighting their ability to enhance hemostasis, improve wound adhesion, reduce bacterial adherence, and facilitate exudate removal, and discusses advancements in the development and application of such composite dressings for antibacterial hemostatic purposes.
June 2026 in “Revista Brasileira de Saúde” This study reviewed current scientific evidence on the use of exosomes for treating alopecias, finding they may stimulate dermal papilla cell proliferation and modulate inflammation, though challenges in standardization and long-term efficacy remain.
This study found that social hair plucking in captive rhesus macaques may share traits with both prosocial and aggressive behaviors and is associated with alopecia and hair cortisol levels.
June 2026 in “The Egyptian Journal of Neurology Psychiatry and Neurosurgery” This review discusses the potential of mesenchymal stem cells and their secretome, mainly extracellular vesicles, in Parkinson's disease therapy, highlighting their neuroprotective abilities and therapeutic prospects, but it reports no clinical results.
June 2026 in “Health Nanotechnology” This narrative review suggests that nanoformulated phytochemicals hold promise for managing polycystic ovarian syndrome, but their efficacy and safety compared to standard treatments require further validation through clinical studies.
June 2026 in “Frontiers in Materials” This review examines advancements in "smart" hydrogel dressings for complex wound healing, highlighting innovations in materials that provide multifunctionality, such as responsive drug delivery and regenerative capabilities. The study also addresses potential challenges in clinical application, like manufacturing and regulatory hurdles.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review compiles current insights into alopecia areata's epidemiology, immune mechanisms, diagnosis, treatment options, including novel JAK inhibitors, and its severe psychosocial impact, while also highlighting emerging research areas.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This source reviews alopecia areata, highlighting its epidemiology, immune-related causes, diagnostic methods, and the shift in treatment with JAK inhibitors like baricitinib and ritlecitinib, marking the first disease-modifying options for this hair loss condition.
June 2026 in “Drug Delivery and Translational Research” This study developed a spring-driven microneedle booster that improved early and cumulative delivery of minoxidil, accelerating hair regrowth compared to traditional roller methods in an androgenetic alopecia model.
This review evaluates the clinical efficacy of platelet-rich plasma therapy in dermatology, highlighting recent research findings and discussing its potential and limitations without reporting new clinical results.
May 2026 in “International Journal of Drug Delivery Technology” This review discusses PRP therapy's history, mechanisms, and innovations in its use across various medical fields, but provides no new clinical results; the authors highlight challenges like standardization and regulatory issues.
May 2026 in “Frontiers in Oncology” In this study, alopecia areata was associated with a statistically significant reduction in melanoma incidence, but not in overall skin cancer risk, highlighting the need for cautious interpretation due to heterogeneity.
April 2026 in “International Journal of Nanomedicine” This review explores quercetin's potential in multifunctional theranostic systems, highlighting its bioactivity and the challenges of improving its clinical application through innovative strategies like nanoencapsulation, while noting that research in this area is underdeveloped.
March 2026 in “Frontiers in Medicine” In this review, recent studies on muscle atrophy are highlighted, revealing insights into its complex pathogenesis, therapeutic interventions such as hormone therapy, and diagnostic advancements, while emphasizing the need for personalized approaches and addressing challenges like small sample sizes and methodological diversity.
March 2026 in “Tissue Engineering and Regenerative Medicine” In this review, the authors discuss recent advancements in underwater adhesion technologies, specifically highlighting mussel-inspired catechol-based adhesives, which offer strong underwater bonding through various interfacial interactions and the influence of dopamine-modified polymeric tissue adhesives.
January 2026 in “Immunity & Inflammation” This review discusses a "stochastic multi-hit model" to explain the onset, progression, and recurrence of vitiligo and other autoimmune skin diseases, emphasizing genetic and environmental influences, immune cell interactions, and unexplored mechanistic gaps.
January 2026 in “Journal of Hair Restoration and Regenerative Medicine” This review discusses methods to better identify unsafe donor areas in patients with diffuse unpatterned alopecia, emphasizing non-surgical management when specific diagnostic criteria are met, but reports no new clinical results.
January 2026 in “Journal of the American Academy of Dermatology” This article provides an educational overview of emerging regenerative technologies for hair growth, highlighting potential therapies like mesenchymal stem cells and platelet-rich plasma while noting their current experimental status and the need for standardized protocols and long-term safety data.